ADME testing refers to the pharmacokinetic testing of a compound in living organism and known as ADME/Tox. Drug development is a cost and time intensive process. The traditional drug development process includes toxicity and efficacy testing in in-vivo environment which is responsible for late stage failure of drugs in human body, as the results observed in animal models and human are different. To overcome this drug failure hurdle drug manufacturers are incorporating ADME toxicity testing in early drug developmental phases.
Scope of the Report:This report studies the ADME Toxicology Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the ADME Toxicology Testing market by product type and applications/end industries.
Geographically, North America is expected to have the largest market share in terms of revenue followed by Europe during the forecast period. Larger base of drug manufacturing organizations coupled with supportive government regulations pertaining to drug development are key drivers for the growth of this regional market. Additionally, increasing R&D investments related to drug discovery is also expected to propel growth of this market. Asia Pacific is expected to have a lucrative growth owing to rapidly improving healthcare infrastructure, rising spending in healthcare & diagnostic centers, increasing patient awareness levels and increased access to healthcare services in the emerging economies of India and China.
The global ADME Toxicology Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of ADME Toxicology Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers Accelrys (Dassault Systemes)
Agilent Technologies
Bio-Rad Laboratories
Promega
Sigma Aldrich
Thermo Fisher Scientific
Cyprtorex
CytoPulse
Entelos
LI-COR Biosciences
Mattek
Miltenyi Biotec
Molecular Toxicology
Quintiles
RTI Health Solutions
SBW
Xenobiotic Detection Systems
Xenometrix
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers Toxicology Testing
ADME Testing
Market Segment by Applications, can be divided into In Vivo
In Vitro
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
